Literature DB >> 24463723

Molecular characteristics of vancomycin-resistant Enterococcus faecium from a tertiary care hospital in Chengdu, China: molecular characteristics of VRE in China.

M Kang1, Y Xie, C He, Z X Chen, L Guo, Q Yang, J Y Liu, Y Du, Q S Ou, L L Wang.   

Abstract

The aim of this study was to characterize vancomycin-resistant Enterococcus faecium (VREfm) isolates phenotypically and molecularly, and investigate associations between the virulence factors enterococcal surface protein (esp), hyaluronidase (hyl), and collagen adhesin (acm) and colonization/infection. A total of 126 E. faecium [66 VREfm and 60 vancomycin-susceptible (VSEfm)] were collected in West China Hospital. Nine E. faecium isolates (7 VREfm and 2 VSEfm) were selected at random for comparative study in a large region from China. Minimum inhibitory concentrations (MICs) were measured by Etest and agar dilution, vancomycin resistance genes (vanA, vanB, and vanC) and virulence genes (esp, acm, and hyl) were detected by polymerase chain reaction (PCR). Thirty-four VREfm underwent repetitive sequence-based PCR (rep-PCR) and multi-locus sequence typing (MLST). One linezolid-resistant isolate (MIC = 8 μg/ml) was found; none were tigecycline resistant. All 73 VREfm (28 infective strains and 45 intestinal colonizers) had the vanA gene and VanA phenotype. Positivity for esp, hyl, and acm in VREfm was 79.5, 46.6, and 86.3%, respectively, which was higher than in VSEfm (54.8, 27.4, and 56.5%, respectively). Among VSEfm, positivity for acm in isolates from pleural or cerebrospinal fluid (84.6%) was higher than that from blood (32.4%). There were 11 rep-PCR types (similarity >95%) and MLST revealed nine sequence types (STs) among the selected isolates. Most VREfm and all VSEfm belonged to clonal complex 17. A new ST was found, with allele sequence (15, 1, 38, 1, 1, 1, 1). In China, most VREfm seem to belong to the classical nosocomial CC17 clone, and many of them have acquired virulence genes, further strengthening a hospital-adapted type.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24463723     DOI: 10.1007/s10096-013-2029-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients.

Authors:  Teresa M Coque; Rob Willems; Rafael Cantón; Rosa Del Campo; Fernando Baquero
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

2.  Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation.

Authors:  Willem J B Van Wamel; Antoni P A Hendrickx; Marc J M Bonten; Janetta Top; George Posthuma; Rob J L Willems
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

Authors:  V Shankar; A S Baghdayan; M M Huycke; G Lindahl; M S Gilmore
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

5.  A variant enterococcal surface protein Esp(fm) in Enterococcus faecium; distribution among food, commensal, medical, and environmental isolates.

Authors:  Tracy J Eaton; Michael J Gasson
Journal:  FEMS Microbiol Lett       Date:  2002-11-05       Impact factor: 2.742

6.  Clonal outbreak of ST17 multidrug-resistant Enterococcus faecium harbouring an Inc18-like::Tn1546 plasmid in a haemo-oncology ward of a Spanish hospital.

Authors:  Sylvia Valdezate; Consuelo Miranda; Ana Navarro; Ana R Freitas; Jorge J Cabrera; Gema Carrasco; Teresa M Coque; Elena Jiménez-Romano; Juan A Saéz-Nieto
Journal:  J Antimicrob Chemother       Date:  2012-01-06       Impact factor: 5.790

7.  A PCR assay for identification of Enterococcus faecium.

Authors:  S Cheng; F K McCleskey; M J Gress; J M Petroziello; R Liu; H Namdari; K Beninga; A Salmen; V G DelVecchio
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

8.  Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium.

Authors:  Vanessa Vankerckhoven; Tim Van Autgaerden; Carl Vael; Christine Lammens; Sabine Chapelle; Rosaria Rossi; Daniela Jabes; Herman Goossens
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen.

Authors:  Sreedhar R Nallapareddy; Kavindra V Singh; Pablo C Okhuysen; Barbara E Murray
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

10.  Bloodstream isolates of Enterococcus faecium enriched with the enterococcal surface protein gene, esp, show increased adhesion to eukaryotic cells.

Authors:  Bodil Lund; Charlotta Edlund
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more
  9 in total

1.  Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).

Authors:  P J Simner; H Adam; M Baxter; M McCracken; G Golding; J A Karlowsky; K Nichol; P Lagacé-Wiens; M W Gilmour; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

Review 2.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

3.  Vancomycin-resistant enteroccus faecium and enterococcus faecalis isolated from education hospital of iran.

Authors:  Hossein Samadi Kafil; Mohammad Asgharzadeh
Journal:  Maedica (Buchar)       Date:  2014-12

Review 4.  Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.

Authors:  Miklos Fuzi; Dora Szabo; Rita Csercsik
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

5.  Antimicrobial resistance pattern, virulence determinants and molecular analysis of Enterococcus faecium isolated from children infections in Iran.

Authors:  Azin Sattari-Maraji; Fereshteh Jabalameli; Narges Node Farahani; Reza Beigverdi; Mohammad Emaneini
Journal:  BMC Microbiol       Date:  2019-07-08       Impact factor: 3.605

6.  Identification and characterization of resistance and pathogenicity of Enterococcus spp. in samples of donor breast milk.

Authors:  Luana Andrade Mendes Santana; Nívea Nara Novais Andrade; Lucas Santana Coelho da Silva; Caline Novais Teixeira Oliveira; Breno Bittencourt de Brito; Fabrício Freire de Melo; Cláudio Lima Souza; Lucas Miranda Marques; Márcio Vasconcelos Oliveira
Journal:  World J Clin Pediatr       Date:  2020-11-19

7.  Molecular epidemiology of vancomycin-resistant Enterococcus faecium clinical isolates in a tertiary care hospital in southern Thailand: a retrospective study.

Authors:  Phanvasri Saengsuwan; Kamonnut Singkhamanan; Siribhorn Madla; Natnicha Ingviya; Chonticha Romyasamit
Journal:  PeerJ       Date:  2021-05-20       Impact factor: 2.984

8.  High Prevalence of vanM in Vancomycin-Resistant Enterococcus faecium Isolates from Shanghai, China.

Authors:  Chunhui Chen; Jingyong Sun; Yan Guo; Dongfang Lin; Qinglan Guo; Fupin Hu; Demei Zhu; Xiaogang Xu; Minggui Wang
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

9.  Virulence Determinants and Antimicrobial Resistance Patterns of Vancomycin-resistant Enterococcus faecium Isolated from Different Sources in Southwest Iran.

Authors:  Maniya Arshadi; Mahmood Mahmoudi; Moloud Sadat Motahar; Saber Soltani; Mohammad Reza Pourmand
Journal:  Iran J Public Health       Date:  2018-02       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.